PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institut Pasteur, Université de Paris, Innovation Lab: Vaccines, Paris, France.\', \'National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency, Virology and Cell Technology Laboratory, Pathumthani, Thailand.\', \'Viroxis, Paris, France.\', \'Institut Pasteur, Université de Paris, Lyssavirus Epidemiology and Neuropathology Unit, Paris, France.\', \'Armed Forces Biomedical Research Institute (IRBA), Microbiology and infectious diseases department, Brétgny-sur-Orge, France.\', \'Institut Pasteur, Université de Paris, Evolutionary Genomics of RNA viruses unit, Paris, France.\', \'Institut Pasteur, Université de Paris, Laboratory of Mouse Genetics, Paris, France.\', \'Institut Pasteur, Université de Paris, Experimental Neuropathology unit, Paris, France.\', \'Institut Pasteur, Université de Paris, INSERM U1223, Innate Immunity unit, Paris, France.\', \'Institut Pasteur, Université de Paris, Innovation Lab: Vaccines, Paris, France. frederic.tangy@pasteur.fr.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41467-021-26506-2
?:doi
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 34725327
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
?:title
  • A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all